furazolidone has been researched along with pargyline in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (60.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Palm, D; Planz, G; Quiring, K | 1 |
Keiser, H; Lovenberg, W; Robinson, DS; Sjoerdsma, A | 1 |
DeQuattro, VL; Sjoerdsma, A | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
5 other study(ies) available for furazolidone and pargyline
Article | Year |
---|---|
Rates of recovery of irreversibly inhibited monoamine oxidases: a measure of enzyme protein turnover.
Topics: Animals; Brain; Carbon Isotopes; Furazolidone; Half-Life; Hydrazines; Intestinal Mucosa; Intestine, Small; Leucine; Liver; Male; Mitochondria; Mitochondria, Liver; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Pargyline; Proteins; Rats; Tranylcypromine | 1972 |
Effects of drugs on human blood platelet and plasma amine oxidase activity in vitro and in vivo.
Topics: Adolescent; Adult; Amines; Animals; Benzene Derivatives; Blood Platelets; Carbon Isotopes; Cyanides; Female; Furazolidone; Humans; Hydrazines; In Vitro Techniques; Iproniazid; Isocarboxazid; Isoniazid; Kinetics; Male; Middle Aged; Mitochondria, Liver; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Nialamide; Pargyline; Phenelzine; Plasma; Rats; Tranylcypromine; Tryptamines | 1968 |
Origin of urinary tyramine and tryptamine.
Topics: Anti-Bacterial Agents; Dietary Carbohydrates; Female; Furazolidone; Glucose; Humans; Intestines; Male; Neomycin; Pargyline; Tryptamines; Tyramine | 1967 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |